mrs KENDALL HUSSEY

Issues related to behavioral health services and prescription drug monitoring programs; 988 Suicide and Crisis Lifeline; SUPPORT Act reauthorization proposals, including S.2433 - SUPPORT for Patients and Communities Reauthorization Act of 2023 and H.R.4531 - the Support for Patients and Communities Reauthorization (SUPPORT) Act of 2023; H.R. 4099 - the RECONNECTS Act of 2023; implementation of FY 2024 CJS and Labor-HHS appropriations bills; FY 2025 CJS and Labor-HHS appropriations bills.

Issues related to 340B Drug Pricing Program; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Issues related to surprise billing; Issues related to telehealth; 1115 Medicaid Waiver; Issues related to the health care workforce; Issues related to maternal health; Freestanding ERs in relation to H.R. 1694 - Emergency Care Improvement Act; Implementation of H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments in relation to H.R. 2665 - The Supporting Safety Net Hospitals Act; Site-neutral payment policies in relation to H.R. 3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); S. 2840 - Bipartisan Primary Care and Health Workforce Act; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.

Children's Hospital GME funding; Implementation of H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. 117-328); FY 24 Appropriations.

Issues related to 340B Drug Pricing Program; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Issues related to surprise billing; Issues related to telehealth; 1115 Medicaid Waiver; Issues related to the health care workforce; Issues related to maternal health; Freestanding ERs in relation to H.R. 1694 - Emergency Care Improvement Act; Implementation of H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments in relation to H.R. 2665 - The Supporting Safety Net Hospitals Act; Site-neutral payment policies in relation to H.R. 3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); S. 2840 - Bipartisan Primary Care and Health Workforce Act; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.

Issues related to electronic provider payments.

H.R.6487, No Fees for EFTs Act; issues related to fees for healthcare related electronic fund transfers.

Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce; Legislative and regulatory proposals affecting home care and hospice, including S. 100/H.R. 547 - the Better Care Better Jobs Act; S.2137/H.R.5159 - Preserving Access to Home Health Act of 2023; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.

Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce; Legislative and regulatory proposals affecting home care and hospice, including S. 100/H.R. 547 - the Better Care Better Jobs Act; S.2137/H.R.5159 - Preserving Access to Home Health Act of 2023; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).

Issues related to 340B Drug Pricing Program; Rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Surprise billing; Telehealth; 1115 Medicaid Waiver; Health care workforce; Maternal health; Freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments (H.R. 2665 - The Supporting Safety Net Hospitals Act); Site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S. 2840 - Bipartisan Primary Care and Health Workforce Act); H.R. 3290 - 340B Drug Pricing Program; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.

Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Surprise billing; Telehealth; 1115 Medicaid Waiver; Health care workforce; Maternal health; Freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments (H.R. 2665 - The Supporting Safety Net Hospitals Act); Site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S. 2840 - Bipartisan Primary Care and Health Workforce Act); H.R. 3290 - 340B Drug Pricing Program; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.

Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); and NCI designation.

Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); and the 340B Drug Pricing Program.

Higher Education Act Reauthorization; H.R. 5933 - Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act; H.R. 6585 - Bipartisan Workforce Pell Act; H.R.6951 - College Cost Reduction Act; the Department of Education's Notice of Proposed Rulemaking; FY 2023 and 2024 appropriations, including Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, toxic exposure in veterans, and additive manufacturing; Implementation and funding for CHIPS and Science Act (P.L. 117-80), including issues related to funding for the Regional Technology and Innovation Hub program; Implementation of the Consolidated Appropriations Act, 2023 (H.R.2617/P.L. 117-328).

FY 2023 and 2024 Appropriations, including Regional Biocontainment Laboratories (RBLs), PAHPA reauthorization, including S.2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R.4420 - Preparedness and Response Reauthorization Act; and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act.

Issues related to animal welfare; H.R.5399 - Humane Cosmetics Act of 2023; H.R.5041/S.2555 - Better CARE for Animals Act of 2023; H.R.3183/S.1488 - EATS Act of 2023.

FY 2024 Appropriations; funding for recovery housing and substance use disorders (SUD); expanding access to Medication-Assisted Treatment (MAT); mental health and SUD legislation; H.R.4088/S.1991 - CAREER Act of 2023; H.R.2400/S.1165 - Reentry Act of 2023; S. 3393 - SUPPORT for Patients and Communities Reauthorization Act; and H.R.4531 - The Support for Patients and Communities Reauthorization (SUPPORT) Act of 2023.

Issues related to behavioral health services and prescription drug monitoring programs; SUPPORT Act reauthorization proposals, including S. 3393/S. 3106/S. 2433/H.R. 4531 - the SUPPORT for Patients and Communities Reauthorization Act; H.R. 4099 - the RECONNECTS Act of 2023; FY 2024 and FY 2025 CJS and Labor-HHS appropriations bills.

Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce. Legislative and regulatory proposals affecting home care and hospice, including S. 100/H.R. 547 - Better Care Better Jobs Act; implementation of the Consolidated Appropriations Act, 2023 (PL 117-328); and S. 2137/H.R. 5128/H.R. 5159 - Preserving Access to Home Health Act of 2023.

Issues related to home care and hospice, telehealth, Medicare reimbursement; Legislative and regulatory proposals affecting home care and hospice.

Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; hospital reimbursement, including sequestration; prescription drug pricing; Surprise billing; telehealth; 1115 Medicaid Waiver; health care workforce; maternal health; freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments (H.R. 2665 - The Supporting Safety Net Hospitals Act); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S. 2840 - Bipartisan Primary Care and Health Workforce Act); and 340B Drug Pricing Program (H.R. 3290); and The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (S.3430).

Children's Hospital GME funding; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); FY 24 Appropriations.

Issues regarding Medicare reimbursement for respiratory devices (H.R. 5555 - DMEPOS Relief Act of 2023).

Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023, H.R.5378 - Lower Costs, More Transparency Act); and H.R. 3290 - 340B Drug Discount Program; NCI designation.

Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023, H.R.5378 - Lower Costs, More Transparency Act); and H.R. 3290 - 340B Drug Discount Program.

Issues related to funding for university research opportunities via FY 2023 and 2024 federal appropriations, FY 2024 defense authorization bill, Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, additive manufacturing.; Implementation and funding for CHIPS and Science Act (P.L. 117-80) including issues related to funding for the Regional Technology and Innovation Hub program.; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); National Science Foundation (NSF) Engine funding.

Cybersecurity research funding; implementation of the FY 2023 National Defense Authorization Act (P.L. 117-347); FY 2024 National Defense Authorization Act (PL 118-31), including Mission Acceleration Center, DCTC program.

Issues related to animal welfare; H.R. 1624 - the Puppy Protection Act; H.R. 4417/S. 2019 - the Ending Agricultural Trade Suppression (EATS) Act; H.R. 5041/S. 2555 - the Better Collaboration, Accountability, and Regulatory Enforcement (CARE) for Animals Act; and FY 2024 Appropriations.

FY 2024 Appropriations; funding for recovery housing and substance use disorders (SUD); expanding access to Medication-Assisted Treatment (MAT); mental health and SUD legislation; CAREER Act (H.R. 5736/S.2730); Reentry Act of 2023 (H.R.2400); SUPPORT for Patients and Communities Reauthorization Act (S. 3393); and The Support for Patients and Communities Reauthorization (SUPPORT) Act of 2023 (H.R.4531).

Issues related to funding for Medicaid home and community-based services, Centers for Medicare and Medicaid Services Ensuring Access to Medicaid Services (CMS-2442-P) Proposed Rule.

Issues related to behavioral health services and prescription drug monitoring programs; SUPPORT Act reauthorization proposals, including S. 3393/S. 3106/S. 2433/H.R. 4531 - the SUPPORT for Patients and Communities Reauthorization Act; H.R. 4099 - the RECONNECTS Act of 2023; FY 2024 CJS and Labor-HHS appropriations bills.

Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce. Legislative and regulatory proposals affecting home care and hospice, including S. 100/H.R. 547 - Better Care Better Jobs Act; implementation of the Consolidated Appropriations Act, 2023 (PL 117-328); and S. 2137/H.R. 5128/H.R. 5159 - Preserving Access to Home Health Act of 2023.

Issues related to home care and hospice, telehealth, Medicare reimbursement. Legislative and regulatory proposals affecting home care and hospice.

Children's Hospital GME funding; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); FY 24 Appropriations.

Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; hospital reimbursement, including sequestration; prescription drug pricing; Surprise billing; telehealth; 1115 Medicaid Waiver; health care workforce; maternal health; Texas 1115 Medicaid waiver; freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).

Immigration issues regarding visa processing.

Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023, H.R.5378 - Lower Costs, More Transparency Act); and H.R. 3290 - 340B Drug Discount Program.

Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023, H.R.5378 - Lower Costs, More Transparency Act); and H.R. 3290 - 340B Drug Discount Program.

FY 2023 and 2024 Appropriations, including Regional Biocontainment Laboratories (RBLs), PAHPA reauthorization, including S. 2333 - Pandemic and All-Hazards Preparedness and Response Act.

Higher Education Act Reauthorization; and the Department of Education's Notice of Proposed Rulemaking; FY 2023 and 2024 appropriations, including Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, toxic exposure in veterans, additive manufacturing; Implementation and funding for CHIPS and Science Act (P.L. 117-80) including issues related to funding for the Regional Technology and Innovation Hub program; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).

Issues related to animal welfare; H.R. 1624 - the Puppy Protection Act; H.R. 4417/S. 2019 - the Ending Agricultural Trade Suppression (EATS) Act; H.R. 5041/S. 2555 - the Better Collaboration, Accountability, and Regulatory Enforcement (CARE) for Animals Act; and FY 2024 Appropriations.

FY 2024 Appropriations; funding for recovery housing and substance use disorders (SUD); expanding access to Medication-Assisted Treatment (MAT); mental health and SUD legislation; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); H.R. 4088/S. 1991 - CAREER Act; H.R.2400 - Reentry Act of 2023; SUPPORT Act reauthorization proposals.

Medicaid home- and community-based services funding; Issues related to funding for Medicaid home and community-based services, alignment of Medicare and Medicaid Programs to protect the dually eligible population, the definition of private duty nursing, and section 409 of H.R. 6000 - Cures 2.0 Act. Centers for Medicare and Medicaid Services Ensuring Access to Medicaid Services (CMS-2442-P) Proposed Rule.

Issues related to behavioral health services and prescription drug monitoring programs; SUPPORT Act reauthorization proposals, including S. 2433 - the SUPPORT for Patients and Communities Reauthorization Act of 2023, H.R. 4531 - the Support for Patients and Communities Reauthorization Act; H.R. 4099 - the RECONNECTIONS Act of 2023.

Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023); and H.R. 3290 - 340B Drug Discount Program.

Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023); and H.R. 3290 - 340B Drug Discount Program.

2023 Farm Bill; federal support for biopharmaceutical research facilities utilizing plant-based inputs and research into use of agricultural waste for conversion to biofuels; federal support for biopharmaceutical research facilities utilizing plant-based inputs and research into use of agricultural waste for conversion to biofuels.

Issues related to funding for university research opportunities via FY 2023 and 2024 federal appropriations, FY 2024 defense authorization bill, Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, additive manufacturing; Implementation and funding for CHIPS and Science Act (P.L. 117-80) including issues related to funding for the Regional Technology and Innovation Hub program; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).

Issues related to animal welfare; H.R. 1624 - the Puppy Protection Act; and FY 2024 Appropriations.

Issues related to home care and hospice, telehealth, Medicare reimbursement. Legislative and regulatory proposals affecting home care and hospice.

Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce. Legislative and regulatory proposals affecting home care and hospice, including Better Care Better Jobs Act (S. 100/ H. R. 547); implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); and S.2137 - A bill to amend title XVIII of the Social Security Act to ensure stability in payments to home health agencies under the Medicare program.

FY 2024 Appropriations; funding for recovery housing and substance use disorders (SUD); expanding access to Medication-Assisted Treatment (MAT); mental health and SUD legislation; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); H.R. 5736/S.2730 - CAREER Act (115th Congress); H.R.2400 - Reentry Act of 2023; SUPPORT Act reauthorization proposals.

Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; hospital reimbursement, including sequestration; prescription drug pricing; Surprise billing; telehealth; 1115 Medicaid Waiver; health care workforce; maternal health; Texas 1115 Medicaid waiver; freestanding ERs (H.R. 1694); implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).

Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; hospital reimbursement, including sequestration; prescription drug pricing; Surprise billing; telehealth; 1115 Medicaid Waiver; health care workforce; maternal health; Texas 1115 Medicaid waiver; freestanding ERs (H.R. 1694); implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).

Medicaid home- and community-based services funding; Issues related to funding for Medicaid home and community-based services, alignment of Medicare and Medicaid Programs to protect the dually eligible population, the definition of private duty nursing, and section 409 of H.R. 6000, the Cures 2.0 Act. Centers for Medicare and Medicaid Services Ensuring Access to Medicaid Services (CMS-2442-P) Proposed Rule.

Issues related to behavioral health services and prescription drug monitoring programs; S. 3476 - SUPPORT Act of 2022 reauthorization proposals; H.R. 4099 - RECONNECTS Act of 2023.

Funding for university programs.

Issues related to home care and hospice, telehealth, Medicare reimbursement. Legislative and regulatory proposals affecting home care and hospice. Better Care Better Jobs Act (S. 100/ H. R. 547).

Issues related to home care and hospice, telehealth, Medicare reimbursement. Legislative and regulatory proposals affecting home care and hospice. Better Care Better Jobs Act (S. 100/ H. R. 547).

Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; hospital reimbursement, including sequestration; prescription drug pricing; Surprise billing; telehealth; 1115 Medicaid Waiver; health care workforce; maternal health; Texas 1115 Medicaid waiver; freestanding ERs (H.R. 1694); implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).

Children's Hospital GME funding; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); FY 24 Appropriations.

Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; hospital reimbursement, including sequestration; prescription drug pricing; Surprise billing; telehealth; 1115 Medicaid Waiver; health care workforce; maternal health; Texas 1115 Medicaid waiver; freestanding ERs (H.R. 1694); implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).

Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).

Issues and funding related to health care workforce challenges; and implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).

Issues related to funding for university research opportunities via FY 2023 and 2024 federal appropriations, FY 2024 defense authorization bill, Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, additive manufacturing.; Implementation and funding for CHIPS and Science Act (P.L. 117-80) including issues related to funding for the Regional Technology and Innovation Hub program.; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).

2023 Farm Bill.

FY 2023 and 2024 Appropriations, including Regional Biocontainment Laboratories (RBLs), implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); PAHPA reauthorization.

Issues related to animal welfare; H.R. 1624 - the Puppy Protection Act; and FY 2024 Appropriations.

FY 2024 Appropriations; funding for recovery housing and substance use disorders (SUD); expanding access to Medication-Assisted Treatment (MAT); mental health and SUD legislation; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).

Issues related to behavioral health services and prescription drug monitoring programs.

Issues related to home care and hospice, telehealth, Medicare reimbursement.; Impact of COVID-19, including telehealth and the Provider Relief Fund.; 1115 Waiver.; FMAP increase/HCBS.; Workforce.; HEAT Act (S. 4854/H.R.3371), Choose Home Care Act of 2021 (S. 2562/H.R. 5514), Build Back Better Act (H.R.5376).; HEAT Act (S. 4854/H.R.3371), Choose Home Care Act of 2021 (S. 2562/H.R. 5514); Legislative and regulatory proposals affecting home care and hospice.; Home health rural add on payment adjustment.; Value based purchasing and bundling.; Hospice payment policy.; Home health non-physician certification authority.; Chronic care management proposals.; Medicare Advantage hospice proposals.; CMS Home Health Conditions of Participation.; Review Choice Demonstration.; HEAT Act (S. 4854/H.R.3371), Choose Home Care Act of 2021 (S. 2562/H.R. 5514), Preserving Access to Home Health Care Act of 2022 (H.R. 8581/S. 4605).

Issues related to home care and hospice, telehealth, Medicare reimbursement.; Impact of COVID-19, including telehealth and the Provider Relief Fund.; COVID-19 relief funding within the American Rescue Plan Act (P.L. 117-2), HEAT Act (S. 4854/H.R.3371),; FY 2022 Appropriations, 1115 Waiver, and FMAP increase/HCBS.; HEAT Act (H.R. 3371).; FY 2022 Appropriations; 1115 Waiver; FMAP increase/HCBS; Workforce.; COVID-19 relief funding within the American Rescue Plan Act (P.L. 117-2), HEAT Act (S. 4854/H.R.3371), Choose Home Care Act of 2021 (S. 2562/H.R. 5514), Build Back Better Act (H.R.5376), the Protecting Medicare and American Farmers from Sequester Cuts Act (S.610), and FY 2022 Consolidated Appropriations Act (P.L. 117-103); HEAT Act (S. 4854/H.R.3371), Choose Home Care Act of 2021 (S. 2562/H.R. 5514).

National Defense Authorization Act for Fiscal Year 2022 (P.L. 117-81); U.S. Family Health Plan Program.

Children's Hospital funding; COVID-19 pandemic relief funding; Broadband funding; FY 2023 appropriations and budget reconciliation legislation; American Rescue Plan Act (P.L. 117-2); Infrastructure Investment and Jobs Act (P.L. 117-58); Further Extending Government Funding Act (P.L. 117-70); Children's Hospital GME funding; Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 (H.R. 6833).

COVID-19 pandemic response and Provider Relief Fund; Supply chain reform; American Rescue Plan Act (P.L. 117-2); Health insurance exchange regulations; Health insurance reform; Health information technology and telehealth funding; 340B Drug Pricing Program and prescription drug pricing; Surprise billing; Maternal and child health; Dr. Lorna Breen Health Care Provider Protection Act (H.R. 1667); Telehealth; Health care workforce; Rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Section 1115 Medicaid waiver; Issues related to 340B Drug Pricing Program; prescription drug pricing; the Provider Relief Fund; COVID relief; 1115 Medicaid Waiver; maternal health; freestanding ERs; the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); Medicare sequestration; hospital reimbursement; rural health; 340B Drug Pricing Program.

Issues related to Medicare sequestration; COVID-19 pandemic and provider funding; health care workforce; the Dr. Joanne Smith Memorial Rehabilitation Innovation Centers Act (S. 2834); the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328).

Issues related to Medicare sequestration; COVID-19 pandemic and provider funding; health care workforce; FY 2023 Labor-HHS Appropriations; Dr. Joanne Smith Memorial Rehabilitation Innovation Centers Act (S. 2834); the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328).

Issues related to animal welfare; FY 2023 Appropriations, Puppy Protection Act (S. 1835/H.R. 2840), Shark Fin Sales Elimination Act (S. 1106), Prevent All Soring Tactics (PAST) Act (S. 2295), Humane Cosmetics Act (S. 3357/H.R. 6207), Preventing Future Pandemics Act of 2021 (S. 37/H.R. 151), FDA Modernization Act of 2021 (S. 2952/H.R.2565), The Humane Cosmetics Act (S. 3357), COMPETES Act (H.R. 4521)/the U.S. Innovation and Competition Act (S. 1260).

FY 2023 Appropriations; funding for recovery housing and substance use disorders; Expanding access to Medication-Assisted Treatment (MAT); mental health and SUD legislation; Excellence in Recovery Housing Act (S. 2901/HR 8868); Comprehensive Addiction and Recovery Act (S. 987); Restoring Hope for Mental Health and Well-Being Act of 2022 (H.R. 7666); the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328).

Issues related to funding for university research opportunities via FY 2022 and 2023 federal appropriations, Infrastructure and defense authorization bills, Regional Biocontainment Laboratories (RBLs) and other federal opportunities.; Issues related to research funding for the Regional Technology and Innovation Hub program, concrete, cybersecurity, toxic exposure in veterans, additive manufacturing.; The Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328).

Higher Education Act Reauthorization; Department of Education's Notice of Proposed Rulemaking for Certification Procedures; FY 2022 and 2023 Appropriations, including Regional Biocontainment Laboratories (RBLs).; Issues related to research funding for the Regional Technology and Innovation Hub program, cybersecurity, concreate, toxic exposure in veterans, additive manufacturing.; The SBIR and STTR Extension Act of 2022 (S. 4900); the Vieques Recovery and Redevelopment Act (S. 405/HR 1317); the Patent Trial and Appeal Board Reform Act of 2022 (S. 4417); the Endless Frontier Act/U.S. Innovation And Competition Act Of 2021 (S. 1260); COMPETES Act (H.R. 4521)/Creating Helpful Incentives to Produce Semiconductors (CHIPS) and Science Act (H.R. 4346); the Honoring our PACT Act of 2022 (H.R. 3967); and the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328).

Issues related to mental and behavioral health services and prescription drug monitoring programs, Improving Access to Behavioral Health Integration Act (S. 4306).

Issues related to mental and behavioral health services and prescription drug monitoring programs, Improving Access to Behavioral Health Integration Act (S. 4306).

Issues related to health care coordination, mental health, behavioral health, and substance use disorder.

Issues related to health care coordination, mental health, behavioral health, and substance use disorder.

Issues related to health care coordination, mental health, behavioral health, and substance use disorder.

Issues related to home care and hospice, telehealth, Medicare reimbursement.; Impact of COVID-19, including telehealth and the Provider Relief Fund.; COVID-19 relief funding within the American Rescue Plan Act (P.L. 117-2), HEAT Act (S. 4854/H.R.3371),; FY 2022 Appropriations, 1115 Waiver, and FMAP increase/HCBS.; HEAT Act (H.R. 3371).; FY 2022 Appropriations; 1115 Waiver; FMAP increase/HCBS; Workforce.; COVID-19 relief funding within the American Rescue Plan Act (P.L. 117-2), HEAT Act (S. 4854/H.R.3371), Choose Home Care Act of 2021 (S. 2562/H.R. 5514), Build Back Better Act (H.R.5376), the Protecting Medicare and American Farmers from Sequester Cuts Act (S.610), and FY 2022 Consolidated Appropriations Act (P.L. 117-103); HEAT Act (S. 4854/H.R.3371), Choose Home Care Act of 2021 (S. 2562/H.R. 5514)

Issues related to home care and hospice, telehealth, Medicare reimbursement.; Impact of COVID-19, including telehealth and the Provider Relief Fund.; 1115 Waiver.; FMAP increase/HCBS.; Workforce.; HEAT Act (S. 4854/H.R.3371), Choose Home Care Act of 2021 (S. 2562/H.R. 5514), Build Back Better Act (H.R.5376).; HEAT Act (S. 4854/H.R.3371), Choose Home Care Act of 2021 (S. 2562/H.R. 5514); Legislative and regulatory proposals affecting home care and hospice.; Home health rural add on payment adjustment.; Value based purchasing and bundling.; Hospice payment policy.; Home health non-physician certification authority.; Chronic care management proposals.; Medicare Advantage hospice proposals.; CMS Home Health Conditions of Participation.; Review Choice Demonstration.; HEAT Act (S. 4854/H.R.3371), Choose Home Care Act of 2021 (S. 2562/H.R. 5514), Preserving Access to Home Health Care Act of 2022 (H.R. 8581/S. 4605)

COVID-19 pandemic response and Provider Relief Fund; Supply chain reform; American Rescue Plan Act (P.L. 117-2); Health insurance exchange regulations; Health insurance reform; Health information technology and telehealth funding; 340B Drug Pricing Program and prescription drug pricing; Surprise billing; Maternal and child health; Dr. Lorna Breen Health Care Provider Protection Act (H.R. 1667); Telehealth; Health care workforce; Rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Section 1115 Medicaid waiver.

Children's Hospital funding; COVID-19 pandemic relief funding; Broadband funding; FY 2023 appropriations and budget reconciliation legislation; American Rescue Plan Act (P.L. 117-2); Infrastructure Investment and Jobs Act (P.L. 117-58); Further Extending Government Funding Act (P.L. 117-70); Children's Hospital GME funding; Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 (H.R. 6833).

Issues related to funding for university research opportunities via FY 2022 and 2023 federal appropriations, infrastructure and defense authorization bills, Regional Biocontainment Laboratories (RBLs) and other federal opportunities.; Issues related to research funding for EPSCoR, cybersecurity, toxic exposure in veterans, additive manufacturing.

FY 2022 and 2023 Appropriations, including Regional Biocontainment Laboratories (RBLs), PREVENT Pandemics Act (S.3799); Honoring our PACT Act of 2022 (H.R. 3967).

FY 2023 National Defense Authorization Act (NDAA).

Issues related to animal welfare; FY 2023 Appropriations, Puppy Protection Act (S. 1835/H.R. 2840), Shark Fin Sales Elimination Act (S. 1106), Prevent All Soring Tactics (PAST) Act (S. 2295), Humane Cosmetics Act (S. 3357/H.R. 6207), Preventing Future Pandemics Act of 2021 (S. 37/H.R. 151), FDA Modernization Act of 2021 (S. 2952/H.R.2565), The Humane Cosmetics Act (S. 3357), COMPETES Act (H.R. 4521)/the U.S. Innovation and Competition Act (S. 1260).

Issues related to mental and behavioral health services and prescription drug monitoring programs.

Issues related to telehealth services for behavioral and mental health services, care coordination, prescription drug monitoring programs, 988 hotline implementation, and the Improving Access to Behavioral Health Integration Act (S. 4306).

Issues related to Medicare sequestration; COVID-19 pandemic and provider funding; health care workforce; FY 2023 Labor-HHS Appropriations; and the Dr. Joanne Smith Memorial Rehabilitation Innovation Centers Act (S. 2834).

Issues related to Medicare sequestration; COVID-19 pandemic and provider funding; health care workforce; and the Dr. Joanne Smith Memorial Rehabilitation Innovation Centers Act (S. 2834).

FY 2023 Appropriations; funding for recovery housing and substance use disorders; Expanding access to Medication-Assisted Treatment (MAT); mental health and SUD legislation; Excellence in Recovery Housing Act (S. 2901/HR 8868); Comprehensive Addiction and Recovery Act (S. 987); Restoring Hope for Mental Health and Well-Being Act of 2022 (H.R. 7666).

FY 2022 budget reconciliation legislation; American Rescue Plan Act (P.L. 117-2); Infrastructure Investment and Jobs Act (P.L. 117-58); Further Extending Government Funding Act (P.L. 117-70); Prescription drug pricing; Surprise billing; Maternal and child health; Accelerating Kids Access to Care Act (S. 1544/H.R. 3089); Dr. Lorna Breen Health Care Provider Protection Act (H.R. 1667); Disproportionate share hospital payments; Medicaid waivers; Provider Relief Fund and COVID-19 pandemic response; Medicare and Medicaid reimbursement.

Children's Hospital funding; COVID-19 pandemic relief funding; Broadband funding; FY 2023 appropriations and budget reconciliation legislation; American Rescue Plan Act (P.L. 117-2); Infrastructure Investment and Jobs Act (P.L. 117-58); Further Extending Government Funding Act (P.L. 117-70).

Strategic and policy advice on general health care issues.

Issues related to home care and hospice, telehealth, Medicare reimbursement.; Impact of COVID-19, including telehealth and the Provider Relief Fund.; 1115 Waiver.; FMAP increase/HCBS.; Workforce.; HEAT Act (S. 4854/H.R.3371), Choose Home Care Act of 2021 (S. 2562/H.R. 5514), Build Back Better Act (H.R.5376).; HEAT Act (S. 4854/H.R.3371), Choose Home Care Act of 2021 (S. 2562/H.R. 5514).

Issues related to home care and hospice, telehealth, Medicare reimbursement.; Impact of COVID-19, including telehealth and the Provider Relief Fund.; COVID-19 relief funding within the American Rescue Plan Act (P.L. 117-2), HEAT Act (S. 4854/H.R.3371),; FY 2022 Appropriations, 1115 Waiver, and FMAP increase/HCBS.; HEAT Act (H.R. 3371).; FY 2022 Appropriations; 1115 Waiver; FMAP increase/HCBS; Workforce.; COVID-19 relief funding within the American Rescue Plan Act (P.L. 117-2), HEAT Act (S. 4854/H.R.3371), Choose Home Care Act of 2021 (S. 2562/H.R. 5514), Build Back Better Act (H.R.5376), the Protecting Medicare and American Farmers from Sequester Cuts Act (S.610), and FY 2022 Consolidated Appropriations Act (P.L. 117-103); HEAT Act (S. 4854/H.R.3371), Choose Home Care Act of 2021 (S. 2562/H.R. 5514).

COVID-19 pandemic response and provider funding; American Rescue Plan Act (P.L. 117-2); FY 2023 Appropriations; Infrastructure and budget reconciliation legislation; Drug pricing; Mental health reform.

COVID-19 pandemic response and provider funding; American Rescue Plan Act (P.L. 117-2); FY 2023 appropriations; infrastructure and budget reconciliation legislation; drug pricing; mental health reform; issues related to COVID-19 pandemic response and provider funding; and health care workforce.

Higher Education Act Reauthorization; Issues related to the Higher Education Emergency Relief Fund (HEERF); The Vieques Recovery and Redevelopment Act (S. 405/HR 1317); Endless Frontier Act/U.S. Innovation And Competition Act Of 2021 (S. 1260); COMPETES Act (H.R. 4521), Honoring our PACT Act of 2022 (H.R. 3967) and Build Back Better Act (H.R. 5376) FY 2022 and 2023 Appropriations, including Regional Biocontainment Laboratories (RBLs).

Funding for university research opportunities via FY 2022 and 2023 federal appropriations, Infrastructure and defense authorization bills, Regional Biocontainment Laboratories (RBLs) and other federal opportunities. Funding support for the University's efforts to address toxic exposure in veterans.

Issues related to animal welfare, including animal welfare state ballot initiatives; FY 2023 Appropriations, Puppy Protection Act (S. 1835/H.R. 2840); Shark Fin Sales Elimination Act (S. 1106); Prevent All Soring Tactics (PAST) Act (S. 2295); Humane Cosmetics Act (S. 3357/H.R. 6207); Preventing Future Pandemics Act of 2021 (S. 37/H.R. 151); The Humane Cosmetics Act (S. 3357); and COMPETES Act (H.R. 4521)/the U.S. Innovation and Competition Act (S. 1260).

FY 2023 Appropriations funding for recovery housing and substance use disorders; expanding access to Medication-Assisted Treatment (MAT) mental health and SUD legislation; Excellence in Recovery Housing Act (S. 2901/HR 8868); Comprehensive Addiction and Recovery Act (S. 987); and Restoring Hope for Mental Health and Well-Being Act of 2022 (H.R. 7666).

Issues related to behavioral health services and prescription drug monitoring programs.

Issues related to telehealth services for behavioral and mental health.

FY 2022 budget reconciliation legislation; American Rescue Plan Act (P.L. 117-2); Infrastructure Investment and Jobs Act (P.L. 117-58); Further Extending Government Funding Act (P.L. 117-70); Prescription drug pricing; Surprise billing; Maternal and child health; Accelerating Kids Access to Care Act (S. 1544/H.R. 3089); Dr. Lorna Breen Health Care Provider Protection Act (H.R. 1667); Disproportionate share hospital payments; Medicaid waivers; Provider Relief Fund and COVID-19 pandemic response; Medicare and Medicaid reimbursement.

COVID-19 pandemic response, testing, vaccination policies and provider reporting; Supply chain reform; FY 2022 appropriations and budget reconciliation legislation; American Rescue Plan Act (P.L. 117-2); Infrastructure Investment and Jobs Act (P.L. 117-58); Further Extending Government Funding Act (P.L. 117-70); Health insurance exchange regulations; Health insurance reform; Health information technology and telehealth funding; 340B Drug Pricing Program and prescription drug pricing; Surprise billing; Maternal and child health; Dr. Lorna Breen Health Care Provider Protection Act (H.R. 1667).

Issues related to home care and hospice, telehealth, Medicare reimbursement and state's health insurance program legislation.; Legislative and regulatory proposals affecting home care and hospice.; Home health rural add on payment adjustment.; Value based purchasing and bundling.; Hospice payment policy.; Home health non-physician certification authority.; Chronic care management proposals.; Medicare Advantage hospice proposals.; CMS Home Health Conditions of Participation.; Home Health Pre-Claim Review Demonstration program.; Disposal of controlled substances.; Review Choice Demonstration; Impact of COVID-19, including telehealth.; COVID-19 relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response; Issues related to home care and hospice, telehealth, Medicare reimbursement.; Impact of COVID-19, including telehealth and the Provider Relief Fund.; COVID-19 relief funding within the American Rescue Plan Act (P.L. 117-2), HEAT Act (S. 4854/H.R.3371),; FY 2022 Appropriations, 1115 Waiver, and FMAP increase/HCBS.; HEAT Act (H.R. 3371).; FY 2022 Appropriations; 1115 Waiver; FMAP increase/HCBS; Workforce.; COVID-19 relief funding within the American Rescue Plan Act (P.L. 117-2), HEAT Act (S. 4854/H.R.3371), Choose Home Care Act of 2021 (S. 2562/H.R. 5514), Build Back Better Act (H.R.5376), the Protecting Medicare and American Farmers from Sequester Cuts Act (S.610), and FY 2022 Consolidated Appropriations Act (P.L. 117-103); HEAT Act (S. 4854/H.R.3371), Choose Home Care Act of 2021 (S. 2562/H.R. 5514)

Strategic and policy advice on general health care issues, including Medicare Advantage, Medicaid redeterminations, and the unwinding of the public health emergency.

COVID-19 pandemic response and provider funding; FY 2022 and FY 2023 Appropriations; Infrastructure and budget reconciliation legislation.

COVID-19 pandemic response and provider funding; American Rescue Plan Act (P.L. 117-2); FY 2022 and 2023 Appropriations; Infrastructure and budget reconciliation legislation.

FY 2023 National Defense Authorization Act (NDAA).

Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics; American Rescue Plan Act (P.L. 117-2); FY 2022 and 2023 Appropriations, including Regional Biocontainment Laboratories (RBLs), PREVENT Pandemics Act (S.3799).

Funding for university research opportunities via FY 2022 and 2023 federal appropriations, Infrastructure and defense authorization bills, Regional Biocontainment Laboratories (RBLs) and other federal opportunities. Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics.

Monitor activity on animal welfare; American Rescue Plan Act (P.L. 117-2); FY 2022 and 2023 Appropriations, Further Extending Government Funding Act (H.R.6119); Puppy Protection Act (S. 1835/H.R. 2840), Shark Fin Sales Elimination Act (S. 1106), Prevent All Soring Tactics (PAST) Act (S. 2295), Humane Cosmetics Act (S. 3357/H.R. 6207), Preventing Future Pandemics Act of 2021 (S. 37/H.R. 151), The Humane Cosmetics Act (S. 3357), COMPETES Act (H.R. 4521).

FY 2022 Labor-HHS Appropriations; funding for recovery housing and substance use disorders; Expanding access to Medication-Assisted Treatment (MAT); mental health and SUD legislation; Excellence in Recovery Housing Act (S. 2901/HR 8868); Comprehensive Addiction and Recovery Act (S. 987); FY 2022 Consolidated Appropriations Act (P.L. 117-103) regarding HRSA Rural Centers of Excellence.

Advocacy related to non-opioid pain management devices.

Advocacy related to non-opioid pain management devices.

COVID-19 pandemic response and provider funding; American Rescue Plan Act (P.L. 117-2), FY 2022 Appropriations; Infrastructure and budget reconciliation legislation.

Immigration issues regarding visa processing.

COVID-19 pandemic response and provider funding; American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations; Wastewater surveillance; infrastructure and budget reconciliation legislation.

Funding for university research opportunities via FY 2021 and 2022 federal appropriations, Infrastructure and defense authorization bills, Regional Biocontainment Laboratories (RBLs) and other federal opportunities. Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics.

National Defense Authorization Act (NDAA) 2022.

Higher Education Act Reauthorization; Issues related to the Higher Education Emergency Relief Fund (HEERF); The Vieques Recovery and Redevelopment Act (S. 405/HR 1317); American Rescue Plan Act (P.L. 117-2); Endless Frontier Act/U.S. Innovation And Competition Act Of 2021 (S. 1260); Build Back Better Act (H.R. 5376); and Infrastructure Investment and Jobs Act (H.R. 3684). FY 2022 Appropriations, including Regional Biocontainment Laboratories (RBLs).

Issues related to home care and hospice, telehealth, Medicare reimbursement and state's health insurance program legislation.; Legislative and regulatory proposals affecting home care and hospice.; Home health rural add on payment adjustment.; Value based purchasing and bundling.; Hospice payment policy.; Home health non-physician certification authority.; Chronic care management proposals.; Medicare Advantage hospice proposals.; CMS Home Health Conditions of Participation.; Home Health Pre-Claim Review Demonstration program.; Disposal of controlled substances.; Review Choice Demonstration; Impact of COVID-19, including telehealth.; COVID-19 relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response; Issues related to home care and hospice, telehealth, Medicare reimbursement.; Impact of COVID-19, including telehealth and the Provider Relief Fund.; COVID-19 relief funding within the American Rescue Plan Act (P.L. 117-2), HEAT Act (S. 4854/H.R.3371),; FY 2022 Appropriations, 1115 Waiver, and FMAP increase/HCBS.; HEAT Act (H.R. 3371).

Monitor activity on animal welfare, generally, and lobby on issues related to horse slaughter, as well as the American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations; Further Extending Government Funding Act (H.R.6119); Puppy Protection Act (S. 1835/H.R. 2840); Shark Fin Sales Elimination Act (S. 1106); Prevent All Soring Tactics (PAST) Act (S. 2295); Humane Cosmetics Act (S. 3357/H.R. 6207); and Preventing Future Pandemics Act of 2021 (S. 37/H.R. 151).

FY 2022 Labor-HHS Appropriations; funding for recovery housing and substance use disorders; Expanding access to Medication-Assisted Treatment (MAT); Excellence in Recovery Housing Act (S. 2901/HR 8868); Comprehensive Addiction and Recovery Act (S. 987); Consolidated Appropriations Act, 2021 (HR 133) regarding HRSA Rural Centers of Excellence.

Children's Hospital funding; COVID-19 pandemic relief funding; Broadband funding; FY 2022 appropriations and budget reconciliation legislation; American Rescue Plan Act (P.L. 117-2); Infrastructure Investment and Jobs Act (P.L. 117-58); Further Extending Government Funding Act (P.L. 117-70).

COVID-19 pandemic response, testing, vaccination policies and provider reporting; Supply chain reform; FY 2022 appropriations and budget reconciliation legislation; American Rescue Plan Act (P.L. 117-2); Infrastructure Investment and Jobs Act (P.L. 117-58); Further Extending Government Funding Act (P.L. 117-70); Health insurance exchange regulations; Health insurance reform; Health information technology and telehealth funding; 340B Drug Pricing Program and prescription drug pricing; Surprise billing; Maternal and child health; Dr. Lorna Breen Health Care Provider Protection Act (H.R. 1667).

Appropriations for library agencies and programs, including infrastructure legislation; Build Americas Libraries Act (S. 127/H.R. 1581). Advocacy for Congress regarding the Build American's Libraries Act to be included in the Build Back Better Act.

Monitor activity on animal welfare, generally, and lobby on issues related to horse slaughter, as well as American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations; Puppy Protection Act (S. 1835), and PAWS for Veterans Therapy Act (S. 613).

Issues related to home care and hospice, telehealth, Medicare reimbursement and state's health insurance program legislation.; Legislative and regulatory proposals affecting home care and hospice.; Home health rural add on payment adjustment.; Value based purchasing and bundling.; Hospice payment policy.; Home health non-physician certification authority.; Chronic care management proposals.; Medicare Advantage hospice proposals.; CMS Home Health Conditions of Participation.; Home Health Pre-Claim Review Demonstration program.; Disposal of controlled substances.; Review Choice Demonstration; Impact of COVID-19, including telehealth.; COVID-19 relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response; Issues related to home care and hospice, telehealth, Medicare reimbursement.; Impact of COVID-19, including telehealth and the Provider Relief Fund.; COVID-19 relief funding within the American Rescue Plan Act (P.L. 117-2), HEAT Act (S. 4854/H.R.3371),; FY 2022 Appropriations, 1115 Waiver, and FMAP increase/HCBS.; HEAT Act (H.R. 3371).

Issues related to HBCUs, including Title III funding, Higher Education Emergency Relief Fund (HEERF), and research grants.

Higher Education Act Reauthorization; Issues related to the Higher Education Emergency Relief Fund (HEERF); The Vieques Recovery and Redevelopment Act (S. 405/HR 1317); American Rescue Plan Act (P.L. 117-2); Endless Frontier Act/U.S. Innovation And Competition Act Of 2021 (S. 1260); Build Back Better Act (H.R. 5376); and Infrastructure Investment and Jobs Act (H.R. 3684). FY 2022 Appropriations, including Regional Biocontainment Laboratories (RBLs).

National Defense Authorization Act (NDAA) 2022.

Funding for university research opportunities via FY 2021 and 2022 federal appropriations, Infrastructure and defense authorization bills, Regional Biocontainment Laboratories (RBLs) and other federal opportunities. Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics; The Vieques Recovery and Redevelopment Act (S. 4398) and related provisions in House Build Back Better legislation (H.R. 5376); preserve charitable donations from Individual Retirement Accounts in Build Back Better legislation.

COVID-19 pandemic response and provider funding; FY 2022 appropriations; American Rescue Plan Act (P.L. 117-2), FY 2022 Appropriations; Infrastructure and budget reconciliation legislation.

COVID-19 pandemic response and provider funding; American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations; Infrastructure and budget reconciliation legislation.

Immigration issues regarding visa processing.

FY 2022 Labor-HHS Appropriations; funding for recovery housing and substance use disorders; Expanding access to Medication-Assisted Treatment (MAT); Excellence in Recovery Housing Act (S. 2901/HR 8868); Comprehensive Addiction and Recovery Act (S. 987); Consolidated Appropriations Act, 2021 (HR 133) regarding HRSA Rural Centers of Excellence.

Telehealth funding.

Children's Hospital funding; COVID-19 pandemic relief funding; Broadband funding; FY 2022 appropriations; American Rescue Plan Act (P.L. 117-2); Infrastructure and budget reconciliation legislation; Children's Hospital GME funding; H.R. 5305 - Extending Government Funding and Delivering Emergency Assistance Act.

Health insurance exchange regulations; Health insurance reform; Health information technology; 340B Drug Pricing Program; Prescription drug pricing; Surprise billing; Children's Hospital funding; COVID-19 testing and vaccine supply chain issues; Telehealth funding; FY 2022 appropriations; American Rescue Plan Act (P.L. 117-2); S. 1544/H.R. 3089 - Maternal and child health; Accelerating Kids Access to Care Act; S. 610 - Dr. Lorna Breen Health Care Provider Protection Act; S. 1544/H.R. 3089 - Infrastructure and budget reconciliation legislation; Accelerating Kids Access to Care Act; H.R. 5376 - Build Back Better Act.

Appropriations for library agencies and programs, including infrastructure legislation; Build Americas Libraries Act (S. 127/H.R. 1581).

Monitor activity on animal welfare; American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations; Puppy Protection Act (S. 1835), PAWS for Veterans Therapy Act (S. 613); and Save America's Forgotten Equines (SAFE) Act (​H.R. 3355); Lobbied related to Horse Slaughter bill in Congress.

Issues related to home care and hospice, telehealth, Medicare reimbursement and state's health insurance program legislation.; Legislative and regulatory proposals affecting home care and hospice.; Home health rural add on payment adjustment.; Value based purchasing and bundling.; Hospice payment policy.; Home health non-physician certification authority.; Chronic care management proposals.; Medicare Advantage hospice proposals.; CMS Home Health Conditions of Participation.; Home Health Pre-Claim Review Demonstration program.; Disposal of controlled substances.; Review Choice Demonstration; Impact of COVID-19, including telehealth.; COVID-19 relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response.

Issues related to home care and hospice, telehealth, Medicare reimbursement and state's health insurance program legislation.; Legislative and regulatory proposals affecting home care and hospice.; Home health rural add on payment adjustment.; Value based purchasing and bundling.; Hospice payment policy.; Home health non-physician certification authority.; Chronic care management proposals.; Medicare Advantage hospice proposals.; CMS Home Health Conditions of Participation.; Home Health Pre-Claim Review Demonstration program.; Disposal of controlled substances.; Review Choice Demonstration; Impact of COVID-19, including telehealth.; COVID-19 relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response; Issues related to home care and hospice, telehealth, Medicare reimbursement.; Impact of COVID-19, including telehealth and the Provider Relief Fund.; COVID-19 relief funding within the American Rescue Plan Act (P.L. 117-2), HEAT Act (S. 4854/H.R.3371),; FY 2022 Appropriations, 1115 Waiver, and FMAP increase/HCBS.; HEAT Act (H.R. 3371).

FY 2022 Labor-HHS Appropriations; funding for recovery housing and substance use disorders; Expanding access to Medication-Assisted Treatment (MAT); Excellence in Recovery Housing Act (HR 8868); Comprehensive Addiction and Recovery Act (S. 987); Consolidated Appropriations Act, 2021 (HR 133) regarding HRSA Rural Centers of Excellence.

Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics; American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations, including Regional Biocontainment Laboratories (RBLs).

Higher Education Act Reauthorization; Issues related to the Higher Education Emergency Relief Fund (HEERF); The Vieques Recovery and Redevelopment Act (S. 4398/H.R. 4605); American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations, including Regional Biocontainment Laboratories (RBLs); Endless Frontier Act/U.S. Innovation And Competition Act Of 2021 (S. 1260), and infrastructure proposals.

Immigration issues regarding visa processing.

COVID-19 relief funding; FY 2022 appropriations; American Rescue Plan Act (P.L. 117-2).

COVID-19 relief funding; FY 2022 appropriations; American Rescue Plan Act (P.L. 117-2).

Strategic and policy advice related to general health care issues and Medicare Advantage.